结果页面 10，板块：医疗保健，行业：生物技术，股市 - 报价与价格
包含价格、市值、市盈率和每股收益的所有股票清单
所有国家
所有交流
- {{item.name}}
- 所有交流
- Amsterdam (3)
- Aquis AQSE (1)
- ASX (45)
- Brussels (7)
- BSE (12)
- Canadian Sec (22)
- Cboe CA (3)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (388)
- Hamburg (1)
- Helsinki (3)
- HKSE (45)
- IOB (24)
- Istanbul (1)
- KOSDAQ (69)
- KSE (10)
- MCE (3)
- MCX (1)
- Mexico (26)
- Milan (3)
- Munich (17)
- NSE (7)
- NYSE (5)
- NYSE American (14)
- NZSE (1)
- Oslo (10)
- OTC Markets EXMKT (40)
- OTC Markets OTCPK (107)
- OTC Markets OTCQB (30)
- OTC Markets OTCQX (5)
- Paris (26)
- São Paulo (13)
- Shanghai (46)
- Shenzhen (43)
- Stockholm (58)
- Stuttgart (21)
- Swiss (10)
- Taipei Exchange (53)
- Taiwan (6)
- Tech Market Large (153)
- Tech Market Middle (83)
- Tech Market Small (209)
- Tel Aviv (13)
- Thailand (2)
- Tokyo (37)
- Toronto (8)
- TSXV (16)
- Vienna (11)
- Warsaw (8)
- XETRA (15)
医疗保健 (1741)
- {{item.name}}
- 所有版块
- 医疗保健 (1741)
生物技术 (1741)
Market Heatmap
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | 预测 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | 预测 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
Alnylam Pharmaceuticals, Inc.
A1LN34.SA
BR
|
R$80.96 16.41 USD |
-1.84
|
R$216.18B 43.82B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$216.18B 43.82B USD | 78.60 | R$1.03 0.21 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.F
DE
|
€273.40 315.6 USD |
+0.15
|
€36.50B 42.14B USD | €10.00 11.54 USD | €273.10 315.25 USD | €273.40 315.6 USD | €36.50B 42.14B USD | 78.11 | €3.50 4.04 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.DE
DE
|
€272.30 314.33 USD |
0
|
€36.36B 41.97B USD | €2.00 2.31 USD | €272.30 314.33 USD | €272.30 314.33 USD | €36.36B 41.97B USD | 77.79 | €3.50 4.04 USD | ||
CSL
CMXHF
US
|
$86.80 — |
+4.35
|
$41.57B — | $200.00 — | $77.86 — | $77.89 — | $41.57B — | 14.06 | $6.17 — | ||
CSL Limited
CSJ.F
DE
|
€74.67 86.19 USD |
+0.23
|
€35.76B 41.28B USD | €100.00 115.43 USD | €74.67 86.19 USD | €74.67 86.19 USD | €35.76B 41.28B USD | 13.77 | €5.42 6.26 USD | ||
Revolution Medicines, Inc.
42Z.F
DE
|
€164.95 190.41 USD |
-2.97
|
€35.07B 40.48B USD | €6.00 6.93 USD | €164.95 190.41 USD | €166.95 192.72 USD | €35.07B 40.48B USD | 0 | -€6.25 -7.2 USD | ||
CSL Limited
CSJA.F
DE
|
€17.90 20.66 USD |
+1.7
|
€34.29B 39.58B USD | €100.00 115.43 USD | €17.90 20.66 USD | €17.90 20.66 USD | €34.29B 39.58B USD | 13.25 | €1.35 1.56 USD | ||
Royalty Pharma plc
RPD.MU
DE
|
€50.42 58.2 USD |
-0.63
|
€29.03B 33.51B USD | €0.00 0 USD | €50.42 58.2 USD | €50.42 58.2 USD | €29.03B 33.51B USD | 30.19 | €1.67 1.93 USD | ||
Moderna, Inc.
MRNA.MX
MX
|
MX$1,425.33 84.4 USD |
+2.95
|
MX$565.55B 33.49B USD | MX$5.65K 334.55 USD | MX$1,380.00 81.71 USD | MX$1,451.38 85.94 USD | MX$565.55B 33.49B USD | 0 | -MX$146.80 -8.6 USD | ||
Royalty Pharma plc
RPD.F
DE
|
€49.32 56.93 USD |
-2.53
|
€28.40B 32.78B USD | €40.00 46.17 USD | €49.32 56.93 USD | €49.32 56.93 USD | €28.40B 32.78B USD | 29.53 | €1.67 1.93 USD | ||
Moderna, Inc.
MRNA.VI
AT
|
€71.56 82.6 USD |
-2.52
|
€28.39B 32.78B USD | €204.00 235.48 USD | €71.25 82.25 USD | €71.56 82.6 USD | €28.39B 32.78B USD | 0 | -€7.15 -8.2 USD | ||
Moderna, Inc.
0QF.MU
DE
|
€71.29 82.29 USD |
+1.47
|
€28.29B 32.65B USD | €240.00 277.04 USD | €71.29 82.29 USD | €71.88 82.97 USD | €28.29B 32.65B USD | 0 | -€7.15 -8.2 USD | ||
Moderna, Inc.
0QF.F
DE
|
€71.20 82.19 USD |
-1.48
|
€28.25B 32.61B USD | €2.12K 2.45K USD | €70.63 81.53 USD | €71.90 83 USD | €28.25B 32.61B USD | 0 | -€7.15 -8.2 USD | ||
|
BeOne Medicines AG
49BA.F
DE
|
€260.00 300.13 USD |
-2.99
|
€26.98B 31.14B USD | €60.00 69.26 USD | €260.00 300.13 USD | €260.00 300.13 USD | €26.98B 31.14B USD | 66.83 | €3.89 4.49 USD | ||
Celltrion, Inc.
068270.KS
KR
|
₩178,200 134.51 USD |
+1.31
|
₩41T 30.85B USD | ₩683K 515.72 USD | ₩172,700 130.36 USD | ₩178,500 134.74 USD | ₩41T 30.85B USD | 0 | ₩0 0 USD | ||
|
Royalty Pharma plc
RPRXN.MX
MX
|
MX$775.06 45.89 USD |
0
|
MX$446.30B 26.43B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$446.30B 26.43B USD | 23.69 | MX$32.71 1.94 USD | ||
BioNTech SE
0A3M.IL
GB
|
$94.99 — |
-0.27
|
$26.13B — | $0.00 — | $94.99 — | $94.99 — | $26.13B — | 5.27 | $18.00 — | ||
|
Roivant Sciences Ltd.
87S.F
DE
|
€30.93 35.7 USD |
+0.62
|
€22.25B 25.68B USD | €350.00 404.02 USD | €30.61 35.33 USD | €30.93 35.7 USD | €22.25B 25.68B USD | 0 | -€0.47 -0.5 USD | ||
|
BioNTech SE
B1NT34.SA
BR
|
R$30.36 6.15 USD |
-2.32
|
R$124.07B 25.15B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$124.07B 25.15B USD | 0 | -R$1.87 -0.3 USD | ||
|
Insmed Incorporated
IM8N.SG
DE
|
€97.48 112.52 USD |
-0.01
|
€21.13B 24.39B USD | €0.00 0 USD | €97.28 112.29 USD | €97.48 112.52 USD | €21.13B 24.39B USD | 0 | -€5.05 -5.8 USD | ||
|
Insmed Incorporated
IM8N.F
DE
|
€97.29 112.31 USD |
-1.46
|
€21.09B 24.34B USD | €290.00 334.76 USD | €97.29 112.31 USD | €97.29 112.31 USD | €21.09B 24.34B USD | 0 | -€5.05 -5.8 USD | ||
|
Incyte Corporation
I1NC34.SA
BR
|
R$296.96 60.19 USD |
0
|
R$118.65B 24.05B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$118.65B 24.05B USD | 16.18 | R$18.35 3.72 USD | ||
|
BioNTech SE
BNTXN.MX
MX
|
MX$1,590.00 94.15 USD |
0
|
MX$402.09B 23.81B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$402.09B 23.81B USD | 0 | -MX$101.12 -5.9 USD | ||
|
BioNTech SE
BNTX.VI
AT
|
€81.50 94.08 USD |
-2.22
|
€20.61B 23.79B USD | €0.00 0 USD | €81.50 94.08 USD | €81.50 94.08 USD | €20.61B 23.79B USD | 0 | -€5.07 -5.8 USD | ||
BioNTech SE
22UA.F
DE
|
€81.15 93.67 USD |
-2.76
|
€20.52B 23.69B USD | €121.00 139.67 USD | €80.90 93.39 USD | €81.15 93.67 USD | €20.52B 23.69B USD | 0 | -€5.07 -5.8 USD | ||
|
Incyte Corporation
ICY.F
DE
|
€99.98 115.41 USD |
-3.49
|
€19.97B 23.06B USD | €165.00 190.47 USD | €99.98 115.41 USD | €99.98 115.41 USD | €19.97B 23.06B USD | 16.07 | €6.22 7.18 USD | ||
|
Genmab A/S
0MGB.IL
GB
|
DKK 1,877.50 275.28 USD |
+3.19
|
DKK 150.35B 22.04B USD | DKK 422.00 61.87 USD | DKK 1,852.00 271.54 USD | DKK 1,878.00 275.35 USD | DKK 150.35B 22.04B USD | 26.52 | DKK 70.77 10.38 USD | ||
|
Incyte Corporation
INCY.MX
MX
|
MX$1,676.03 99.24 USD |
0
|
MX$334.84B 19.83B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$334.84B 19.83B USD | 13.51 | MX$124.03 7.34 USD | ||
|
WuXi Biologics (Cayman) Inc.
1FW2.F
DE
|
€4.08 4.71 USD |
-2.39
|
€16.75B 19.34B USD | €2.50K 2.89K USD | €4.08 4.71 USD | €4.08 4.71 USD | €16.75B 19.34B USD | 27.19 | €0.15 0.17 USD | ||
Innovent Biologics, Inc.
6IB.F
DE
|
€9.59 11.06 USD |
-2.74
|
€16.63B 19.19B USD | €726.00 838.05 USD | €9.59 11.06 USD | €9.90 11.43 USD | €16.63B 19.19B USD | 159.75 | €0.06 0.07 USD | ||
|
WuXi Biologics (Cayman) Inc.
1FW1.F
DE
|
€8.05 9.29 USD |
-2.42
|
€16.53B 19.08B USD | €134.00 154.68 USD | €8.05 9.29 USD | €8.05 9.29 USD | €16.53B 19.08B USD | 26.83 | €0.30 0.35 USD | ||
WuXi Biologics (Cayman)
WXIBF
US
|
$4.40 — |
-5.98
|
$18.07B — | $250.00 — | $4.40 — | $4.40 — | $18.07B — | 25.88 | $0.17 — | ||
|
GENMAB AS N
GE9.DE
DE
|
€246.20 284.2 USD |
0
|
€15.12B 17.45B USD | €77.00 88.88 USD | €246.20 284.2 USD | €246.20 284.2 USD | €15.12B 17.45B USD | 21.31 | €11.55 13.33 USD | ||
Genmab A/S
GNMSF
US
|
$282.16 — |
+2.6
|
$17.32B — | $140.00 — | $275.00 — | $275.00 — | $17.32B — | 21.45 | $13.15 — | ||
Genmab A/S
GE91.F
DE
|
€24.20 27.93 USD |
-2.42
|
€14.86B 17.15B USD | €600.00 692.6 USD | €24.20 27.93 USD | €24.20 27.93 USD | €14.86B 17.15B USD | 20.86 | €1.16 1.34 USD | ||
Jazz Pharmaceuticals plc
J7Z.F
DE
|
€210.90 243.45 USD |
-0.66
|
€13.25B 15.29B USD | €50.00 57.72 USD | €208.80 241.03 USD | €210.90 243.45 USD | €13.25B 15.29B USD | 2343.33 | €0.09 0.1 USD | ||
|
BridgeBio Pharma, Inc.
2CL.F
DE
|
€67.38 77.78 USD |
-1.01
|
€13.20B 15.23B USD | €70.00 80.8 USD | €67.38 77.78 USD | €67.38 77.78 USD | €13.20B 15.23B USD | 0 | -€3.29 -3.7 USD | ||
Ascendis Pharma A/S
A71.F
DE
|
€206.00 237.79 USD |
0
|
€12.65B 14.6B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €12.65B 14.6B USD | 0 | €0.00 0 USD | ||
Verona Pharma plc
I9SA.F
DE
|
€90.20 104.12 USD |
0
|
€12.13B 14.01B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €12.13B 14.01B USD | 0 | €0.00 0 USD | ||
Exelixis, Inc.
EX9.F
DE
|
€48.00 55.41 USD |
-1.92
|
€12.07B 13.93B USD | €1.59K 1.83K USD | €48.00 55.41 USD | €48.00 55.41 USD | €12.07B 13.93B USD | 18.11 | €2.65 3.06 USD | ||
Sino Biopharmaceutical Limited
SBMFF
US
|
$0.78 — |
-6.28
|
$13.83B — | $2.00K — | $0.78 — | $0.78 — | $13.83B — | 38.89 | $0.02 — | ||
ALTEOGEN Inc.
196170.KQ
KR
|
₩337,500 254.76 USD |
+1.96
|
₩18T 13.63B USD | ₩364K 274.41 USD | ₩326,000 246.08 USD | ₩346,000 261.17 USD | ₩18T 13.63B USD | 0 | ₩0 0 USD | ||
|
Axsome Therapeutics, Inc.
19X.F
DE
|
€210.50 242.99 USD |
-2.86
|
€10.83B 12.5B USD | €14.00 16.16 USD | €210.50 242.99 USD | €210.50 242.99 USD | €10.83B 12.5B USD | 0 | -€3.27 -3.7 USD | ||
Arrowhead Pharmaceuticals, Inc.
HDP1.F
DE
|
€76.22 87.98 USD |
+1.52
|
€10.74B 12.39B USD | €75.00 86.58 USD | €76.22 87.98 USD | €76.22 87.98 USD | €10.74B 12.39B USD | 0 | -€1.99 -2.2 USD | ||
|
Madrigal Pharmaceuticals, Inc.
YDO1.F
DE
|
€458.50 529.26 USD |
-0.39
|
€10.57B 12.2B USD | €16.00 18.47 USD | €458.50 529.26 USD | €458.50 529.26 USD | €10.57B 12.2B USD | 0 | -€11.84 -13.6 USD | ||
|
Cytokinetics, Incorporated
KK3A.F
DE
|
€73.84 85.24 USD |
-1.34
|
€10.03B 11.57B USD | €37.00 42.71 USD | €73.84 85.24 USD | €73.84 85.24 USD | €10.03B 11.57B USD | 0 | -€6.01 -6.9 USD | ||
|
Bio-Techne Corporation
T1CH34.SA
BR
|
R$12.21 2.47 USD |
-1.37
|
R$57.07B 11.57B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$57.07B 11.57B USD | 101.75 | R$0.12 0.02 USD | ||
ABIVAX Société Anonyme
2X1.F
DE
|
€125.30 144.64 USD |
-2.03
|
€10.00B 11.54B USD | €30.00 34.63 USD | €125.30 144.64 USD | €125.30 144.64 USD | €10.00B 11.54B USD | 0 | -€4.61 -5.3 USD | ||
|
Akeso, Inc.
4RY.F
DE
|
€10.85 12.52 USD |
-4.02
|
€9.99B 11.54B USD | €200.00 230.87 USD | €10.85 12.52 USD | €10.91 12.59 USD | €9.99B 11.54B USD | 0 | -€0.16 -0.1 USD | ||
|
BioMarin Pharmaceutical Inc.
BMRN.VI
AT
|
€51.06 58.94 USD |
-0.23
|
€9.87B 11.39B USD | €0.00 0 USD | €51.06 58.94 USD | €51.06 58.94 USD | €9.87B 11.39B USD | 41.85 | €1.22 1.41 USD | ||
|
BioMarin Pharmaceutical Inc.
BM8.F
DE
|
€50.66 58.48 USD |
-2.5
|
€9.79B 11.3B USD | €100.00 115.43 USD | €50.66 58.48 USD | €50.66 58.48 USD | €9.79B 11.3B USD | 41.52 | €1.22 1.41 USD | ||
|
Sino Biopharmaceutical
SBHMY
US
|
$12.68 — |
0
|
$11.27B — | $128.00 — | $12.68 — | $12.68 — | $11.27B — | 33.36 | $0.38 — | ||
Ionis Pharmaceuticals, Inc.
IONS.MX
MX
|
MX$1,150.00 68.09 USD |
0
|
MX$190.05B 11.25B USD | MX$0.00 0 USD | MX$1,150.00 68.09 USD | MX$1,150.00 68.09 USD | MX$190.05B 11.25B USD | 0 | -MX$28.98 -1.7 USD | ||
|
Financière de Tubize SA
FTD.SG
DE
|
€217.00 250.49 USD |
-0.55
|
€9.66B 11.15B USD | €0.00 0 USD | €217.00 250.49 USD | €218.60 252.34 USD | €9.66B 11.15B USD | 103.33 | €2.10 2.42 USD | ||
|
Financière de Tubize SA
FTD.F
DE
|
€216.60 250.03 USD |
-2.87
|
€9.64B 11.13B USD | €100.00 115.43 USD | €216.60 250.03 USD | €216.60 250.03 USD | €9.64B 11.13B USD | 104.13 | €2.08 2.4 USD | ||
Krystal Biotech, Inc.
4KB.F
DE
|
€325.20 375.39 USD |
-0.21
|
€9.59B 11.07B USD | €18.00 20.78 USD | €325.20 375.39 USD | €325.20 375.39 USD | €9.59B 11.07B USD | 49.72 | €6.54 7.55 USD | ||
|
BioMarin Pharmaceutical Inc.
B1MR34.SA
BR
|
R$140.85 28.55 USD |
0
|
R$54.45B 11.04B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$54.45B 11.04B USD | 39.01 | R$3.61 0.73 USD | ||
|
BioMarin Pharmaceutical Inc.
BMRN.MX
MX
|
MX$959.00 56.78 USD |
0
|
MX$185.36B 10.98B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$185.36B 10.98B USD | 39.36 | MX$24.36 1.44 USD | ||
|
Krystal Biotech, Inc.
4KB.SG
DE
|
€322.50 372.27 USD |
-1.29
|
€9.51B 10.97B USD | €0.00 0 USD | €322.20 371.93 USD | €325.30 375.51 USD | €9.51B 10.97B USD | 49.16 | €6.56 7.57 USD | ||
Bio-Techne Corporation
TE1.F
DE
|
€60.84 70.23 USD |
-0.91
|
€9.48B 10.94B USD | €13.00 15.01 USD | €60.84 70.23 USD | €60.84 70.23 USD | €9.48B 10.94B USD | 98.12 | €0.62 0.72 USD | ||
Sino Biopharmaceutical Limited
SMZ1.F
DE
|
€0.53 0.61 USD |
-3.41
|
€9.42B 10.87B USD | €2.50K 2.89K USD | €0.53 0.61 USD | €0.53 0.61 USD | €9.42B 10.87B USD | 26.48 | €0.02 0.02 USD | ||
|
Bio-Techne Corporation
TECH.MX
MX
|
MX$1,064.35 63.02 USD |
0
|
MX$169.12B 10.01B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$169.12B 10.01B USD | 0 | MX$0.00 0 USD | ||
|
Corcept Therapeutics Incorporated
HTD.F
DE
|
€79.34 91.58 USD |
-1.17
|
€8.52B 9.83B USD | €8.00 9.23 USD | €79.34 91.58 USD | €79.34 91.58 USD | €8.52B 9.83B USD | 255.93 | €0.31 0.36 USD | ||
Halozyme Therapeutics, Inc.
RV7.F
DE
|
€70.68 81.59 USD |
+2.02
|
€8.38B 9.68B USD | €70.00 80.8 USD | €70.68 81.59 USD | €70.68 81.59 USD | €8.38B 9.68B USD | 28.27 | €2.50 2.89 USD | ||
ImmunityBio, Inc.
26CA.F
DE
|
€7.76 8.96 USD |
+0.13
|
€8.13B 9.38B USD | €1.36K 1.57K USD | €7.76 8.96 USD | €7.76 8.96 USD | €8.13B 9.38B USD | 0 | -€0.75 -0.8 USD | ||
|
Halozyme Therapeutics, Inc.
HALO.MX
MX
|
MX$1,327.00 78.57 USD |
0
|
MX$157.40B 9.32B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$157.40B 9.32B USD | 26.59 | MX$49.90 2.95 USD | ||
|
Jazz Pharmaceuticals plc
JAZZN.MX
MX
|
MX$2,500.00 148.03 USD |
0
|
MX$157.04B 9.3B USD | MX$0.00 0 USD | MX$2,500.00 148.03 USD | MX$2,500.00 148.03 USD | MX$157.04B 9.3B USD | 0 | -MX$106.00 -6.2 USD | ||
|
Crinetics Pharmaceuticals, Inc.
6Z4.F
DE
|
€72.50 83.69 USD |
+94.47
|
€7.64B 8.82B USD | €60.00 69.26 USD | €72.50 83.69 USD | €72.50 83.69 USD | €7.64B 8.82B USD | 0 | -€4.51 -5.2 USD | ||
|
TG Therapeutics, Inc.
NKB2.F
DE
|
€48.00 55.41 USD |
+3.45
|
€7.35B 8.48B USD | €464.00 535.61 USD | €48.00 55.41 USD | €48.00 55.41 USD | €7.35B 8.48B USD | 19.12 | €2.51 2.9 USD | ||
Vaxcyte, Inc.
5VA.MU
DE
|
€50.50 58.29 USD |
-0.98
|
€7.29B 8.42B USD | €0.00 0 USD | €50.50 58.29 USD | €50.50 58.29 USD | €7.29B 8.42B USD | 0 | -€6.05 -6.9 USD | ||
|
ALK-Abelló A/S
4AJ0.F
DE
|
€32.14 37.1 USD |
-1.29
|
€7.12B 8.22B USD | €333.00 384.39 USD | €32.14 37.1 USD | €32.14 37.1 USD | €7.12B 8.22B USD | 41.74 | €0.77 0.89 USD | ||
Biocon Limited
BIOCON.BO
IN
|
₹416.10 5.03 USD |
-2.01
|
₹677.53B 8.2B USD | ₹55.32K 669.27 USD | ₹416.00 5.03 USD | ₹426.00 5.15 USD | ₹677.53B 8.2B USD | 148.07 | ₹2.81 0.03 USD | ||
Vaxcyte, Inc.
5VA.F
DE
|
€47.20 54.48 USD |
-3.28
|
€6.82B 7.87B USD | €6.00 6.93 USD | €47.20 54.48 USD | €47.20 54.48 USD | €6.82B 7.87B USD | 0 | -€6.05 -6.9 USD | ||
|
Rhythm Pharmaceuticals, Inc.
1RV.F
DE
|
€96.00 110.82 USD |
+2.13
|
€6.58B 7.6B USD | €49.00 56.56 USD | €96.00 110.82 USD | €96.00 110.82 USD | €6.58B 7.6B USD | 0 | -€2.75 -3.1 USD | ||
Mirum Pharmaceuticals, Inc.
08D.F
DE
|
€104.65 120.8 USD |
-2.29
|
€6.38B 7.37B USD | €15.00 17.32 USD | €104.55 120.69 USD | €104.65 120.8 USD | €6.38B 7.37B USD | 0 | -€11.93 -13.7 USD | ||
ALK-Abelló A/S
0OIR.IL
GB
|
DKK 241.40 35.39 USD |
+61.53
|
DKK 48.46B 7.11B USD | DKK 661.00 96.92 USD | DKK 241.40 35.39 USD | DKK 242.60 35.57 USD | DKK 48.46B 7.11B USD | 149.93 | DKK 1.61 0.24 USD | ||
|
Merus N.V.
2GH.F
DE
|
€79.00 91.19 USD |
0
|
€6.11B 7.05B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €6.11B 7.05B USD | 0 | €0.00 0 USD | ||
Cidara Therapeutics
CDTX
US
|
$221.38 — |
0
|
$6.96B — | $0.00 — | $0.00 — | $0.00 — | $6.96B — | 0 | $0.00 — | ||
|
ALK-Abelló A/S
AKBLF
US
|
$31.35 — |
-22.88
|
$6.95B — | $105.00 — | $31.35 — | $31.35 — | $6.95B — | 35.62 | $0.88 — | ||
|
Merus
MRUS
US
|
$90.00 — |
0
|
$6.83B — | $0.00 — | $0.00 — | $0.00 — | $6.83B — | 0 | $0.00 — | ||
Scholar Rock Holding Corporation
2QK.F
DE
|
€48.14 55.57 USD |
+0.96
|
€5.77B 6.66B USD | €30.00 34.63 USD | €48.14 55.57 USD | €48.14 55.57 USD | €5.77B 6.66B USD | 0 | -€3.03 -3.4 USD | ||
ABIVAX Société Anonyme
AAVXF
US
|
$80.03 — |
0
|
$6.39B — | $500.00 — | $80.03 — | $90.45 — | $6.39B — | 0 | -$5.25 — | ||
Ligand Pharmaceuticals Incorporated
LGDN.F
DE
|
€276.00 318.6 USD |
+1.47
|
€5.53B 6.39B USD | €20.00 23.09 USD | €276.00 318.6 USD | €276.00 318.6 USD | €5.53B 6.39B USD | 40.88 | €6.75 7.79 USD | ||
|
CRISPR Therapeutics AG
CRSPN.MX
MX
|
MX$1,090.00 64.54 USD |
+3.61
|
MX$107.35B 6.36B USD | MX$1.54K 91.13 USD | MX$1,070.00 63.36 USD | MX$1,090.00 64.54 USD | MX$107.35B 6.36B USD | 0 | -MX$108.04 -6.3 USD | ||
|
RemeGen Co., Ltd.
REG.F
DE
|
€8.99 10.38 USD |
-5.88
|
€5.41B 6.25B USD | €50.00 57.72 USD | €8.99 10.38 USD | €8.99 10.38 USD | €5.41B 6.25B USD | 52.90 | €0.17 0.2 USD | ||
Centessa Pharmaceuticals plc
260.F
DE
|
€34.60 39.94 USD |
0
|
€5.35B 6.18B USD | €270.00 311.67 USD | €34.20 39.48 USD | €34.60 39.94 USD | €5.35B 6.18B USD | 0 | -€1.56 -1.8 USD | ||
|
Xenon Pharmaceuticals Inc.
XP0.F
DE
|
€52.50 60.6 USD |
-0.94
|
€5.07B 5.86B USD | €43.00 49.64 USD | €52.50 60.6 USD | €52.50 60.6 USD | €5.07B 5.86B USD | 0 | -€4.12 -4.7 USD | ||
3SBio Inc.
83B.F
DE
|
€1.95 2.25 USD |
-8.14
|
€4.88B 5.64B USD | €1.05K 1.21K USD | €1.95 2.25 USD | €1.95 2.25 USD | €4.88B 5.64B USD | 4.43 | €0.44 0.51 USD | ||
Legend Biotech Corporation
9LB.F
DE
|
€24.00 27.7 USD |
-1.64
|
€4.64B 5.36B USD | €40.00 46.17 USD | €24.00 27.7 USD | €24.00 27.7 USD | €4.64B 5.36B USD | 0 | -€1.21 -1.3 USD | ||
|
HLB Co., Ltd.
028300.KQ
KR
|
₩51,700 39.03 USD |
+6.05
|
₩7T 5.19B USD | ₩979K 738.8 USD | ₩47,650 35.97 USD | ₩51,700 39.03 USD | ₩7T 5.19B USD | 0 | ₩0 0 USD | ||
Apellis Pharmaceuticals Inc
1JK.F
DE
|
€34.11 39.37 USD |
0
|
€4.37B 5.04B USD | €10.00 11.54 USD | €34.11 39.37 USD | €34.11 39.37 USD | €4.37B 5.04B USD | 37.48 | €0.91 1.05 USD | ||
SK Biopharmaceuticals Co., Ltd.
326030.KS
KR
|
₩84,900 64.09 USD |
+1.07
|
₩7T 5.02B USD | ₩102K 77.25 USD | ₩82,700 62.42 USD | ₩85,600 64.61 USD | ₩7T 5.02B USD | 0 | ₩0 0 USD | ||
|
Asymchem Laboratories (Tianjin) Co., Ltd.
7K90.F
DE
|
€12.00 13.85 USD |
-3.23
|
€4.33B 5B USD | €4.00 4.62 USD | €12.00 13.85 USD | €12.00 13.85 USD | €4.33B 5B USD | 30.00 | €0.40 0.46 USD | ||
|
Amicus Therapeutics
FOLD
US
|
$14.49 — |
0
|
$4.55B — | $0.00 — | $0.00 — | $0.00 — | $4.55B — | 0 | $0.00 — | ||
|
Akero Therapeutics
AKRO
US
|
$54.65 — |
0
|
$4.50B — | $0.00 — | $0.00 — | $0.00 — | $4.50B — | 0 | $0.00 — | ||
Viking Therapeutics, Inc.
1VT.F
DE
|
€33.35 38.5 USD |
+2.77
|
€3.87B 4.47B USD | €50.00 57.72 USD | €33.35 38.5 USD | €33.35 38.5 USD | €3.87B 4.47B USD | 0 | -€3.64 -4.2 USD | ||
|
Akero Therapeutics, Inc.
0K4.F
DE
|
€46.53 53.71 USD |
0
|
€3.85B 4.44B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €3.85B 4.44B USD | 0 | €0.00 0 USD | ||
|
ACADIA Pharmaceuticals Inc.
DR6.F
DE
|
€22.31 25.75 USD |
-1.46
|
€3.82B 4.41B USD | €20.00 23.09 USD | €22.31 25.75 USD | €22.31 25.75 USD | €3.82B 4.41B USD | 11.49 | €1.94 2.24 USD | ||
|
Agios Pharmaceuticals, Inc.
AGIO.MX
MX
|
MX$1,222.00 72.36 USD |
0
|
MX$72.67B 4.3B USD | MX$0.00 0 USD | MX$1,222.00 72.36 USD | MX$1,222.00 72.36 USD | MX$72.67B 4.3B USD | 5.16 | MX$236.58 14.01 USD | ||
|
Genscript Biotech
GNNSF
US
|
$1.90 — |
+18.75
|
$4.15B — | $300.00 — | $1.90 — | $1.90 — | $4.15B — | 0 | -$0.25 — | ||
|
没有最喜欢的股票
您还没有喜欢的股票，请将其添加到收藏夹以在此处查看 |
|||||||||||